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INTRODUCTION 
 
A urinary stent is defined as a thin tube, which is inserted in the ureter to prevent or 
treat the obstruction of urine flow from the kidney. Silicone, latex, polyvinylchloride and 
polyurethanes are the most widely used materials for the preparation of stents. Nonetheless, 
severe clinical complications may result from the use of these materials such as fracture, 
encrustation and infection. In some of the cases, the ureteral stents are temporary and it is 
often required a second surgery to remove the stent. The main complications with ureteral 
stents are dislocation, infection, and blockage by encrustation [1]. Recently, a tendency has 
been noticed favouring less invasive approaches (e.g. pharmacological or catheterization) in 
treating patients who exhibit symptoms or signs of urinary retention [2]. Currently, nearly 
100% of the people who have an urological stent are likely to develop a bacterial infection 
within 30 days, which increases morbidity threefold [1]. Different types of temporary and 
permanent stents have been introduced into urological practice to relieve obstructions [3]. 
Particular attention should be devoted to polymers as they represent a highly versatile class of 
materials. Despite the fact that silicon continues to be the gold standard material for 
urological stents, there have been fast developments in manufacturing processes, as well as 
the introduction of new biodegradable materials in order to overcome the drawbacks of the 
available products. Polyurethane continues to be the most widely used material for polymeric 
stents; however it frequently promotes biofilm formation and bacterial adhesion leading to 
severe infections [2]. The concerns regarding existing stents are the motivation to design new 
biodegradable urological stent systems based on natural polymers, specifically 
polysaccharides, which present inherent biocompatibility, anti-bacterial properties and that 
can be tailor-made into a custom suitable stent for a particular patient.  
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MATERIALS AND METHODS 
 
Gelzan CM, k-carrageenan, alginic acid sodium salt, urea, ethanol, potassium chloride 
and calcium chloride were purchased from Sigma-Aldrich (Germany). The potassium 
dihydrogen ortho-phosphate (99.5%), magnesium chloride hexahydrate (99%) were obtained 
from Riedel-de Haën. All reagents were used as received. 
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Hollow tube formulation 
Polymers were dissolved into hot distilled water at different concentrations (6 wt% for 
alginate, 4 wt% for gellan gum and 5 wt% for K-carrageenan. Their blends with gelatin were 
in proportion of 40% of gelatin. The solutions stirred for 1 hour. A template of appropriate 
geometry (compact glass tubes of 1 mm of diameter) was immersed into the polymeric 
solution for 2h. The polymer-coated template was transferred into a reticulation bath (CaCl2 
(0,24 M) or KCl (0,60M) solution) kept at room temperature under constant magnetical 
stirring. This later step allowed the removal of the template without damaging the polymeric 
tubular structure. 
 
 
Figure 1 Technology used to obtain aerogel hollow tubes for biodegradable ureteral stents: 1 - immersion in 
polymer solution; 2 - gelification of this solution surrounding the template; 3 - solvent exchange; 4 - 
supercritical point drying with carbon dioxide and 5 - tubular aerogel structure after template removal. 
 
Characterization 
Artificial urine solution (AUS) was prepared as described by Khandwekar et al [4]. 
The morphology and the inner section of the aerogel tubes (after immersion in AUS) were 
analysed on a Leica Cambridge S360 Scanning Electron Microscope (SEM). The fluid uptake 
capability and the indwelling time (as a function of the weight loss) were measured for a 
period up to 60 days by the immersion of the samples in 10 ml of AUS at 37ºC and 60 rpm. 
The development of encrustation was evaluated following the procedure described by Tunney 
et al [5, 6]. Bacterial adhesion studies were performed according to Khandwekar et al [4], 
using gram-positive Staphylococcus aureus. Finally, the cytotoxicity and cell adhesion studies 
were also executed to compare the developed hollow tubes with a commercial stent. 
Confluent SaOS-2-cells, with a concentration 5x105 cells/ml were harvested and seeded on 
samples of the hollow tubes and of a commercial stent (Biosoft Duo, Sedinger 0.035” 
150cm). 
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RESULTS AND DISCUSSION 
 
In this work, the possibility to prepare hollow tubes from natural origin 
polysaccharides, i.e. alginate, k-carrageenan, gellan gum and a blend of these with gelatin was 
evaluated. Hollow tubes, with a diameter of 2 mm were prepared and characterized in terms 
of surface morphology by SEM (figure 2). 
 
 
 
Figure 2 SEM micrographs of the cross-section of gellan gum : gelatin stent (60:40 % w/w). 
 
Water uptake and polymer degradation were evaluated using an AUS as immersion 
medium. Figure 3 shows a cross-section of a hollow tube in the wet and dry state. 
 
Figure 3 Swelling of developed gellan gum (and its blends with gelatin) aerogel hollow tubes during a 
timeframe of 60 days, with internal diameter of 1mm.  
 
In vitro performance demonstrated that all tubes have high water uptake ability, 
although being able to maintain their shape and integrity upon immersion in AUS. The 
degradation in solution can be tuned between 14 and 60 days. Furthermore, in vitro 
assessment of possible encrustation, i.e. the deposition of magnesium and/or calcium salts on 
the developed stents was also carried out using SEM coupled with energy dispersive x-ray 
spectroscopy (EDS). No encrustation was observed up to 28 days. The ability to resist to 
bacterial adhesion was evaluated with gram-positive Staphylococcus aureus (figure 4). It was 
observed a drastic reduction in bacterial adhesion in comparison with commercial stents  
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Figure 4 Bacterial adhesion on materials incubated with approximately 1 x 108 S. aureus bacterias during 4 h. 
(a) Developed aerogel hollow tubes. Values represent means ± standard deviation from a single experiment 
performed in triplicate, which was representative of three independent experiments. (b) Commercial stent, data 
from Khandwekar et al [4]. 
 
Cytotoxicity and cell adhesion studies were also evaluated comparing the developed 
hollow tubes with a commercial stent. Figure 5 shows the cytotoxicity results obtained for all 
materials tested with cell line SaOS-2. Cytotoxicity tests demonstrated that the material 
prepared does not have a detrimental effect on cell growth being comparable to the 
commercially available stent.  
 
 
Figure 5 Cytotoxicity tests with cell line SaOS-2 in tubes made by alginate (A), alginate : gelatin (AG), K-
carrageenan (K), K-carrageenan : gelatin (KG), gelan gum (GG), gelan gam: gelatin (GGG) and the 
commercial stent. 
 
The results revealed that the proposed materials are major breakthroughs in the 
development of biocompatible and biodegradable urinary stents. 
 
CONCLUSIONS 
 
In this work we demonstrated that it is possible to use natural origin, biodegradable 
polymers (with inherent anti-bacterial properties) to prepare urinary stents with adequate 
morphology. The developed devices do not present encrustation, avoiding the need for a 
second surgery. All the reported characteristics are foreseen as major breakthroughs in the 
development of biocompatible a degradable urinary stents. 
We propose the creation of hollow tubes from natural origin polysaccharides. This 
methodology generates biodegradable stents that are envisaged to compete with the 
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commercially available ones. The products herein evaluated present additional advantages 
such as adequate degradation rates, no encrustation and inherent anti-bacterial properties. 
Hollow tubes, prepared using the reported methodology, when in contact with a body 
physiological medium forms hydrogels, which are hydrophilic polymeric networks, 
biocompatible and non-cytotoxic. The presence of high equilibrium water content renders 
softness, lubricious and flexible characteristics similar to natural tissue. The obtained results 
demonstrate the feasibility to develop biodegradable stents from natural origin 
polysaccharides. 
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